1. Home
  2. COLM vs AKRO Comparison

COLM vs AKRO Comparison

Compare COLM & AKRO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • COLM
  • AKRO
  • Stock Information
  • Founded
  • COLM 1938
  • AKRO 2017
  • Country
  • COLM United States
  • AKRO United States
  • Employees
  • COLM N/A
  • AKRO N/A
  • Industry
  • COLM Apparel
  • AKRO Biotechnology: Pharmaceutical Preparations
  • Sector
  • COLM Consumer Discretionary
  • AKRO Health Care
  • Exchange
  • COLM Nasdaq
  • AKRO Nasdaq
  • Market Cap
  • COLM 3.5B
  • AKRO 3.9B
  • IPO Year
  • COLM 1998
  • AKRO 2019
  • Fundamental
  • Price
  • COLM $60.39
  • AKRO $54.20
  • Analyst Decision
  • COLM Hold
  • AKRO Strong Buy
  • Analyst Count
  • COLM 6
  • AKRO 6
  • Target Price
  • COLM $68.00
  • AKRO $82.50
  • AVG Volume (30 Days)
  • COLM 655.3K
  • AKRO 1.8M
  • Earning Date
  • COLM 07-24-2025
  • AKRO 08-08-2025
  • Dividend Yield
  • COLM 1.99%
  • AKRO N/A
  • EPS Growth
  • COLM N/A
  • AKRO N/A
  • EPS
  • COLM 3.88
  • AKRO N/A
  • Revenue
  • COLM $3,377,052,000.00
  • AKRO N/A
  • Revenue This Year
  • COLM $2.89
  • AKRO N/A
  • Revenue Next Year
  • COLM $2.80
  • AKRO N/A
  • P/E Ratio
  • COLM $15.56
  • AKRO N/A
  • Revenue Growth
  • COLM N/A
  • AKRO N/A
  • 52 Week Low
  • COLM $58.44
  • AKRO $21.02
  • 52 Week High
  • COLM $92.88
  • AKRO $58.40
  • Technical
  • Relative Strength Index (RSI)
  • COLM 41.19
  • AKRO 62.96
  • Support Level
  • COLM $59.74
  • AKRO $53.61
  • Resistance Level
  • COLM $62.71
  • AKRO $56.49
  • Average True Range (ATR)
  • COLM 1.66
  • AKRO 2.40
  • MACD
  • COLM -0.12
  • AKRO -0.08
  • Stochastic Oscillator
  • COLM 21.30
  • AKRO 65.93

About COLM Columbia Sportswear Company

Columbia Sportswear Co makes outdoor and active-lifestyle apparel, footwear, equipment, and accessories that it sells under four primary brands: Columbia, Sorel, Mountain Hardwear, and prAna. The majority of sales are in the United States, but the company also has remarkable sales in its three other geographic segments: Latin American and Asia-Pacific; Europe, Middle East, and Africa; and Canada. The majority of sales are through wholesale channels, including sporting goods and department stores, but the company also operates its own branded stores in each of its geographic segments. Columbia sources products from around the world and uses contract manufacturers outside the United States, predominantly in Asia to manufacture its various products.

About AKRO Akero Therapeutics Inc.

Akero Therapeutics Inc is a clinical-stage biotechnology company focused on developing and commercializing transformative treatments for serious metabolic diseases with high unmet medical needs. Its focus is nonalcoholic steatohepatitis (MASH), or NASH, a disease without any approved therapies. The company's product candidate efruxifermin is an FGF21 analog with properties that have the potential to address the core processes underlying NASH pathogenesis.

Share on Social Networks: